Passage BIO, Inc. Quarterly Return On Equity in % from Q4 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Passage BIO, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q2 2024.
  • Passage BIO, Inc. Return On Equity for the quarter ending June 30, 2024 was -70.7 %, a 17.9% decline year-over-year.
  • Passage BIO, Inc. annual Return On Equity for 2023 was -73.1 %, a 28.3% decline from 2022.
  • Passage BIO, Inc. annual Return On Equity for 2022 was -57 %, a 17.2% decline from 2021.
  • Passage BIO, Inc. annual Return On Equity for 2021 was -48.6 %, a 51% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -70.7 -10.7 -17.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -68.5 -8.04 -13.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -73.1 -16.1 -28.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -69.3 -9.57 -16% Jul 1, 2023 Sep 30, 2023
Q2 2023 -60 -0.36 -0.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -60.5 -4.99 -8.99% Jan 1, 2023 Mar 31, 2023
Q4 2022 -57 -8.37 -17.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59.8 -13.9 -30.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -59.6 -18 -43.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -55.5 -18.6 -50.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -48.6 -16.4 -51% Oct 1, 2021 Dec 31, 2021
Q3 2021 -45.9 -12.4 -36.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -41.6 +1.04 +2.44% Apr 1, 2021 Jun 30, 2021
Q1 2021 -36.9 +50.8 +58% Jan 1, 2021 Mar 31, 2021
Q4 2020 -32.2 -152 -127% Oct 1, 2020 Dec 31, 2020
Q3 2020 -33.5 Jul 1, 2020 Sep 30, 2020
Q2 2020 -42.7 Apr 1, 2020 Jun 30, 2020
Q1 2020 -87.7 Jan 1, 2020 Mar 31, 2020
Q4 2019 119 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.